Synthesis of 3'alpha-carbo-substituted 2',3'-dideoxyribonucleosides from naturally occurring nucleosides. 1999

H Kumamoto, and H Tanaka, and J Ogamino, and H Suzuki, and K Haraguchi, and T Miyasaka
School of Pharmaceutical Sciences, Showa University, Tokyo, Japan.

Naturally occurring ribonucleosides, uridine and adenosine, were converted to their 3'alpha-CH2CO2Me and 3'alpha-CH2PO(OPh)2 2',3'-dideoxy analogues. The present reaction sequence starts with oxidative cleavage of the 2',3'-cis-diol system, and involves radical-mediated reconstruction of furanose ring as the key step.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides

Related Publications

H Kumamoto, and H Tanaka, and J Ogamino, and H Suzuki, and K Haraguchi, and T Miyasaka
January 1992, Nucleic acids symposium series,
H Kumamoto, and H Tanaka, and J Ogamino, and H Suzuki, and K Haraguchi, and T Miyasaka
August 1965, Journal of the American Chemical Society,
H Kumamoto, and H Tanaka, and J Ogamino, and H Suzuki, and K Haraguchi, and T Miyasaka
August 1971, Journal of medicinal chemistry,
H Kumamoto, and H Tanaka, and J Ogamino, and H Suzuki, and K Haraguchi, and T Miyasaka
January 1989, Fortschritte der Chemie organischer Naturstoffe = Progress in the chemistry of organic natural products. Progres dans la chimie des substances organiques naturelles,
H Kumamoto, and H Tanaka, and J Ogamino, and H Suzuki, and K Haraguchi, and T Miyasaka
January 1977, Journal of medicinal chemistry,
H Kumamoto, and H Tanaka, and J Ogamino, and H Suzuki, and K Haraguchi, and T Miyasaka
February 1998, Cellular and molecular life sciences : CMLS,
H Kumamoto, and H Tanaka, and J Ogamino, and H Suzuki, and K Haraguchi, and T Miyasaka
January 2001, Nucleosides, nucleotides & nucleic acids,
H Kumamoto, and H Tanaka, and J Ogamino, and H Suzuki, and K Haraguchi, and T Miyasaka
June 1983, Journal of medicinal chemistry,
H Kumamoto, and H Tanaka, and J Ogamino, and H Suzuki, and K Haraguchi, and T Miyasaka
August 1966, Journal of the American Chemical Society,
H Kumamoto, and H Tanaka, and J Ogamino, and H Suzuki, and K Haraguchi, and T Miyasaka
December 2005, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!